These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2650256)

  • 21. A clinical trial of antilymphocyte globulin in renal transplantation. Failure to observe a significant improvement.
    Dormont J; Kreis H; Leski M; Bach JF; Crosnier J
    Rev Eur Etud Clin Biol; 1972 Apr; 17(4):382-9. PubMed ID: 4627946
    [No Abstract]   [Full Text] [Related]  

  • 22. A collaborative scheme for tissue typing and matching in renal transplantation. 3. A preliminary assessment of the influence of histocompatibility matching grades on the outcome of renal transplantation.
    Festenstein H; Oliver RT; Sachs JA
    Transplant Proc; 1971 Jun; 3(2):1011-4. PubMed ID: 4944043
    [No Abstract]   [Full Text] [Related]  

  • 23. Renal transplantation in the highly sensitized recipient.
    Ildstad ST; Cosimi AB; Delmonico FL; Fuller TC; Tolkoff-Rubin N; Rubin RH; Russell PS
    Transplant Proc; 1987 Feb; 19(1 Pt 1):769-70. PubMed ID: 3274868
    [No Abstract]   [Full Text] [Related]  

  • 24. Outcome of second renal transplants.
    Curtis JJ; Lucas BA; Snieckinski LI; Luke RG
    Proc Clin Dial Transplant Forum; 1977; 7():121-5. PubMed ID: 356032
    [No Abstract]   [Full Text] [Related]  

  • 25. Successful renal allografts in recipients with a positive standard, DTE negative cross-match.
    Barger BO; Shroyer TW; Hudson SL; Deierhoi MH; Barber WH; Curtis JJ; Julian BA; Luke RG; Diethelm AG
    Transplant Proc; 1989 Feb; 21(1 Pt 1):746-7. PubMed ID: 2650253
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunologic evaluation of renal allograft recipients.
    Cerilli J; Holliday JE; Koolemans-Beynen A; Fesperman DP; Williams MA
    Transplant Proc; 1977 Dec; 9(4):1815-7. PubMed ID: 341441
    [No Abstract]   [Full Text] [Related]  

  • 27. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Positive B cell crossmatches in highly sensitized patients--influence of antibody specificity on renal transplant outcome.
    Lazda VA; Pollak R; Mozes MF; Jonasson O
    Transplant Proc; 1987 Feb; 19(1 Pt 1):782-4. PubMed ID: 3547840
    [No Abstract]   [Full Text] [Related]  

  • 29. Preoperative immunomodulation of renal allograft recipients by concomitant immunosuppression and donor-specific transfusions.
    Anderson CB; Tyler JD; Rodey GE; Etheredge EE; Anderman CK; Flye MW; Jendrisak MD; Sicard GA
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1494-7. PubMed ID: 3547868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of pretransplant antibodies on early renal allograft rejection.
    Alarif L; Rodriguez R; Blackburn S; Light JA
    Transplant Proc; 1987 Feb; 19(1 Pt 1):771-2. PubMed ID: 3274869
    [No Abstract]   [Full Text] [Related]  

  • 31. Anti-HLA antibodies following the transplantation of highly sensitised renal allograft recipients.
    Palmer A; Bewick M; Kennedy L; Welsh K; Taube D
    Transplant Proc; 1989 Feb; 21(1 Pt 1):766-7. PubMed ID: 2650263
    [No Abstract]   [Full Text] [Related]  

  • 32. Primary cadaveric renal transplantation using cyclosporine in patients over fifty years of age.
    Mandelbaum DM; Henry ML; Sommer BG; Ferguson RM
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1863-4. PubMed ID: 3274443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of donor age and acute rejection episodes on long-term graft survival in cadaveric kidney transplantations.
    Emiroğlu R; Yagmurdur MC; Karakayali F; Haberal C; Ozcelik U; Colak T; Haberal M
    Transplant Proc; 2005 Sep; 37(7):2954-6. PubMed ID: 16213272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal transplantation in Canada from 1981-86: report of the Canadian Renal Failure Register.
    Jeffery JR; Arbus GS; Hutchinson T; Posen GA
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2171-3. PubMed ID: 2652699
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical aspects of allograft rejection.
    Williams GM
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):71-7. PubMed ID: 4612907
    [No Abstract]   [Full Text] [Related]  

  • 36. Does "responder"/"nonresponder" status influence renal allograft success?
    Ferguson RM; Noreen H; Yunis EJ; Simmons RL; Najarian JS
    Transplant Proc; 1977 Mar; 9(1):69-72. PubMed ID: 325800
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of major histocompatibility complex matching on renal pathology and OKT4/OKT8 (CD4/CD8) ratio in renal allograft rejection.
    Smart YC; Nanra RS; Hibberd AD; Burton RC
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1627-8. PubMed ID: 3152632
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of renal allograft outcomes in combined liver-kidney transplantation versus subsequent kidney transplantation in liver transplant recipients: Analysis of UNOS Database.
    Simpson N; Cho YW; Cicciarelli JC; Selby RR; Fong TL
    Transplantation; 2006 Nov; 82(10):1298-303. PubMed ID: 17130778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. False-positive crossmatch owing to autoantibodies induced by donor-specific transfusions without development of alloantibodies.
    López Blanco OA; Cavalli NH; Raimondi E; Haas EJ; Verruno L; Gotlieb D
    Transplant Proc; 1989 Feb; 21(1 Pt 1):768-70. PubMed ID: 2650264
    [No Abstract]   [Full Text] [Related]  

  • 40. Graft and patient survival after primary cadaver kidney transplantation with special regard to compatibility in the HL-A system.
    Storm B
    Acta Chir Scand Suppl; 1973; 437():1-57. PubMed ID: 4584870
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.